SCHEMBL25216496

SCHEMBL25216496

O=C(O)CCCCOc1ccc(C(=O)/C=C/c2ccccc2)cc1

nearest known ligand 0.82

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 2/20 0.74
▸ BCHE P06276 15/20 0.71
▸ ACHE P22303 14/20 0.71
▸ MAOA P21397 1/20 0.67
▸ MAOB P27338 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25193715 0.96 BCHE (0.70) PPARABCHEACHEMAOAMAOB
SCHEMBL2993225 0.93 PPARA (0.72) PPARABCHEACHE
SCHEMBL2993228 0.93 PPARA (0.72) PPARABCHEACHE
SCHEMBL2989573 0.88 BCHE (0.73) PPARABCHEACHEMAOAMAOB
SCHEMBL2989576 0.88 BCHE (0.73) PPARABCHEACHEMAOAMAOB
SCHEMBL3005010 0.88 BCHE (0.73) PPARABCHEACHEMAOAMAOB
SCHEMBL3001431 0.88 BCHE (0.73) PPARABCHEACHE
SCHEMBL3005012 0.88 BCHE (0.73) PPARABCHEACHEMAOAMAOB
SCHEMBL3001434 0.88 BCHE (0.73) PPARABCHEACHE
SCHEMBL3005112 0.87 MAOB (0.65) PPARABCHEACHEMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014100-A1 Compositions and Methods for Treating Bleeding and Bleeding Disorders YEWSAVIN INC (US) 2026-01-15 — — US disclosed
US-12343317-B2 Compositions and methods for treating bleeding and bleeding disorders YewSavin, Inc. (US) 2025-07-01 — — US disclosed
WO-2024233598-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2024-11-14 — — WO disclosed
EP-4429763-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS Yewsavin, Inc. (US) 2024-09-18 — — EP disclosed
US-20230190679-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-06-22 — — US disclosed
WO-2023086388-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014100-A1 Compositions and Methods for Treating Bleeding and Bleeding Disorders SERPINC1, F2, F13B PPARA 4345/4885BCHE 588/4885ACHE 806/4885
US-20230190679-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS SERPINC1, SERPINE1, SERPINH1 PPARA 4095/4885BCHE 465/4885ACHE 656/4885
US-12343317-B2 Compositions and methods for treating bleeding and bleeding disorders SERPINC1, SERPINE1, SERPINH1 PPARA 4095/4885BCHE 465/4885ACHE 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback